Cumberland Pharmaceuticals (CPIX) Cash from Investing Activities (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Cash from Investing Activities across 17 years of filings, most recently posting -$61173.0 for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$61173.0, up 95.02% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.5 million (down 218.25% YoY), and the FY2025 annual result was -$4.7 million, down 8236.82% from the prior year.
• Cash from Investing Activities came in at -$61173.0 for Q1 2026 at Cumberland Pharmaceuticals, up from -$3.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $680805.0 in Q3 2022 to a low of -$13.5 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is -$95073.0 (2023), against an average of -$1.1 million.
• Across the five-year window, Cash from Investing Activities jumped 728.95% in 2022 and slumped 11363.83% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Cash from Investing Activities stood at -$640772.0 in 2022, then surged by 140.68% to $260639.0 in 2023, then tumbled by 110.29% to -$26809.0 in 2024, then plunged by 11363.83% to -$3.1 million in 2025, then surged by 98.01% to -$61173.0 in 2026.
• The last three Cash from Investing Activities figures came in at -$61173.0 (Q1 2026), -$3.1 million (Q4 2025), and -$690837.0 (Q3 2025), per Business Quant data.